In this regard, by using a HTS screening on 150000 compounds, Saito et al. identified K67, a small noncovalent inhibitor of phospho-p62/KEAP1 interaction, as a molecule capable of restoring the main route of NRF2 degradation in human HCC lines. The gene discussed is SQSTM1; the disease is hepatocellular carcinoma.